Abstract:Histone acetylation modification is governed by the intricate interplay of histone deacetylases (HDACs) and histone acetyltransferases (HATs), where elevated HDAC activity in both neurons and immune cells regulates the expression of genes implicated in pain pathways, promoting neuronal excitability and neuroinflammation, and ultimately, enabling neuropathic pain. Background Neuropathic pain remains a formidable challenge for modern medicine. The first‐line pharmacological therapies exhibit limited efficacy and unfavorable side effect profiles, highlighting an unmet need for effective therapeutic medications. The past decades have witnessed an explosion in efforts to translate epigenetic concepts into pain therapy and shed light on epigenetics as a promising avenue for pain research. Recently, the aberrant activity of histone deacetylase (HDAC) has emerged as a key mechanism contributing to the development and maintenance of neuropathic pain. Aims In this review, we highlight the distinctive role of specific HDAC subtypes in a cell‐specific manner in pain nociception, and outline the recent experimental evidence supporting the therapeutic potential of HDACi in neuropathic pain. Methods We have summarized studies of HDAC in neuropathic pain in Pubmed. Results HDACs, widely distributed in the neuronal and non‐neuronal cells of the dorsal root ganglion and spinal cord, regulate gene expression by deacetylation of histone or non‐histone proteins and involving in increased neuronal excitability and neuroinflammation, thus promoting peripheral and central sensitization. Importantly, pharmacological manipulation of aberrant acetylation using HDAC‐targeted inhibitors (HDACi) has shown promising pain‐relieving properties in various preclinical models of neuropathic pain. Yet, many of which exhibit low‐specificity that may induce off‐target toxicities, underscoring the necessity for the development of isoform‐selective HDACi in pain management. Conclusions Abnormally elevated HDACs promote neuronal excitability and neuroinflammation by epigenetically modulating pivotal gene expression in neuronal and immune cells, contributing to peripheral and central sensitization in the progression of neuropathic pain, and HDACi showed significant efficacy and great potential for alleviating neuropathic pain.

Normalizing HDAC2 Levels in the Spinal Cord Alleviates Thermal and Mechanical Hyperalgesia After Peripheral Nerve Injury and Promotes GAD65 and KCC2 Expression

Suppression of HDAC2 in Spinal Cord Alleviates Mechanical Hyperalgesia and Restores KCC2 Expression in a Rat Model of Bone Cancer Pain.

Regulation of hyaluronic acid synthesis and the role in neuropathic pain following chronic constriction injury in rats

Nerve injury augments Cacna2d1 transcription via CK2-mediated phosphorylation of the histone deacetylase HDAC2 in dorsal root ganglia

Effect of intrathecal ropivacaine on spinal HDAC1 and HDAC2 expression in rats with neuropathic pain

Role of histone deacetylase in spinal cord in maintenance of neuropathic pain in rats

Downregulation of Cdh1 Signalling in Spinal Dorsal Horn Contributes to the Maintenance of Mechanical Allodynia after Nerve Injury in Rats

Kilohertz High-Frequency Electrical Stimulation Ameliorate Hyperalgesia by Modulating Transient Receptor Potential Vanilloid-1 and N-methyl-D-aspartate Receptor-2B Signaling Pathways in Chronic Constriction Injury of Sciatic Nerve Mice.

Histone Deacetylase Inhibitor-Induced Emergence of Synaptic Δ-Opioid Receptors and Behavioral Antinociception in Persistent Neuropathic Pain

Alleviating neuropathic pain mechanical allodynia by increasing Cdh1 in the anterior cingulate cortex

High-frequency Electrical Stimulation Reduced Hyperalgesia and the Activation of the Myd88 and NFκB Pathways in Chronic Constriction Injury of Sciatic Nerve-Induced Neuropathic Pain Mice.

Kilohertz High-Frequency Alternating Current Ameliorate Hyperalgesia and Inhibit the Glial Activation by Modulating TRPV1 and NMDAR2B Signaling Pathways in Chronic Constriction Injury of Sciatic Nerve Mice

P300 Exerts an Epigenetic Role in Chronic Neuropathic Pain Through Its Acetyltransferase Activity in Rats Following Chronic Constriction Injury (CCI)

Astrocytic c-Jun N-terminal kinase-histone deacetylase-2 cascade contributes to glutamate transporter-1 decrease and mechanical allodynia following peripheral nerve injury in rats

NF-κB p65-dependent transcriptional regulation of histone deacetylase 2 contributes to the chronic constriction injury-induced neuropathic pain via the microRNA-183/TXNIP/NLRP3 axis

Axonal accumulation of hyperpolarization-activated cyclic nucleotide-gated cation channels contributes to mechanical allodynia after peripheral nerve injury in rat.

Spinal SIRT1 Activation Attenuates Neuropathic Pain in Mice

Genome-wide Analysis of Histone H3 Lysine 27 Trimethylation Profiles in Sciatic Nerve of Chronic Constriction Injury Rats

Histone deacetylase as emerging pharmacological therapeutic target for neuropathic pain: From epigenetic to selective drugs

Spinal Cord Injury‐induced Attenuation of GABAergic Inhibition in Spinal Dorsal Horn Circuits is Associated with Down‐regulation of the Chloride Transporter KCC2 in Rat

Brainstem Brain-Derived Neurotrophic Factor Signaling is Required for Histone Deacetylase Inhibitor–Induced Pain Relief